Dr. Reiman is Executive Director of the Banner Alzheimer's Institute, Chief Executive Officer of Banner Research, Clinical Director of Neurogenomics at the Translational Genomics Research Institute, Professor of Psychiatry at the University of Arizona, University Professor of Neuroscience at Arizona State University, and Director of the Arizona Alzheimer's Consortium. He and his Banner Alzheimer's Institute colleagues Drs. Pierre Tariot and Jessica Langbaum lead the Alzheimer's Prevention Initiative (API), which has helped to introduce a new era in Alzheimer's prevention research.
Dr. Reiman received his undergraduate and medical degrees at Duke University and his Psychiatry Residency training at Duke and Washington University in St. Louis. Launching his research career as a resident and faculty member under Dr. Marcus Raichle, he and his colleagues introduced brain imaging paradigms and image analysis techniques that have had a profound impact on the study of the human mind and brain.
Dr. Reiman is internationally recognized for his pioneering contributions in brain imaging, genomics, and the cognitive and behavioral neurosciences, the unusually early detection and tracking of Alzheimer's disease, and the accelerated evaluation of Alzheimer's prevention therapies. He and his colleagues hope to provide the evidence needed to help establish a new national standard of dementia care by 2020, they hope to find and support the approval of effective Alzheimer's prevention therapies by 2025, and they have continued to find new ways for researchers from different disciplines and organizations to work together in support of their ambitious goals.
Dr. Reiman an author of more than 300 publications, a principal investigator of several large NIH grants, and a recipient of the Potamkin Prize.
